Development of optimized vectors for gene therapy
AUTOR(ES)
Nabel, Gary J.
FONTE
The National Academy of Sciences
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=33542Documentos Relacionados
- Development of HIV vectors for anti-HIV gene therapy.
- E- vectors: development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy.
- Self-deleting retrovirus vectors for gene therapy.
- Plasmoviruses: nonviral/viral vectors for gene therapy.
- Safety-modified episomal vectors for human gene therapy